rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joseph Truitt

Director

Company insider

Files Form 4 as: Director, Century Therapeutics; Director, Larimar Therapeutics; Chief Executive Officer, Biospecifics Technologies; Chief Executive Officer, Achillion Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
56
Buys
2
Sells
5
Bought
$24K
Sold
$1.6M
Companies
4
Companies where not an officer
2
First trade
5 Jan 2009
Last trade
9 Sep 2026
Last filed
10 Sep 2026

Companies traded

Where they are an officer
Biospecifics TechnologiesDirector, Officer · last 2 Dec 20200 buys · 0 sells
Achillion PharmaceuticalsDirector, Officer · last 28 Jan 20201 buy · 5 sells
Everywhere else they filed: board seats, 10% stakes, other companies
IPSC Century TherapeuticsDirector · Biotechnology · last 9 Sep 20260 buys · 0 sells
LRMR Larimar TherapeuticsDirector · Biotechnology · last 19 May 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Sep 2026filed 10 Sep 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—148,000 at $0.00filing
9 Sep 2026filed 10 Sep 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—148,000 at $0.00filing
19 May 2026filed 20 May 2026LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—55,150 at $0.00filing
19 May 2026filed 20 May 2026LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—55,150 at $0.00filing
13 May 2025filed 14 May 2025LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,000 at $0.00filing
29 May 2024filed 31 May 2024LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,000 at $0.00filing
17 May 2023filed 18 May 2023LRMR Larimar TherapeuticsBiotechnologySEC FORM 4 Bought$10K2,750 at $3.73filing
9 May 2023filed 11 May 2023LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—8,300 at $0.00filing
10 May 2022filed 12 May 2022LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—8,300 at $0.00filing
12 May 2021filed 20 May 2021LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—8,300 at $0.00filing
2 Dec 2020filed 2 Dec 2020Biospecifics Technologiesoption or derivativeSEC FORM 4 Code D$2.5M100,000 at $24.78filing
29 Sep 2020filed 30 Sep 2020LRMR Larimar Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,600 at $0.00filing
28 May 2020filed 19 Oct 2020Biospecifics Technologiesoption or derivativeSEC FORM 4 Code A—100,000 at $0.00filing
28 May 2020filed 29 May 2020Biospecifics Technologiesoption or derivativeSEC FORM 4 Code A—130,000 at $0.00filing
28 Jan 2020filed 29 Jan 2020Achillion PharmaceuticalsSEC FORM 4 Code D$22K3,500 at $6.30filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—142,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—100,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—185,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—632,000filing
28 Jan 2020filed 29 Jan 2020Achillion Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—30,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.